|
|
HEPARAN SULFATE IN NEUROPHYSIOLOGY AND NEUROLOGICAL DISORDERS |
| 5R01NS088496-02 |
YAMAGUCHI, YU |
NINDS |
2016 |
|
|
AN IPSC BASED PLATFORM FOR FUNCTIONALLY ASSESSING GENETIC AND ENVIRONMENTAL RISK |
| 5R01NS088538-03 |
JAENISCH, RUDOLF |
NINDS |
2016 |
|
|
MASS CYTOMETRY ANALYSIS OF SIGNALING DYSFUNCTION IN DUCHENNE MUSCULAR DYSTROPHY |
| 5R01NS089533-03 |
BLAU, HELEN M |
NINDS |
2016 |
|
|
C9ORF72 IN MOTOR SYSTEM BIOLOGY AND ALS |
| 5R01NS089742-03 |
EGGAN, KEVIN C |
NINDS |
2016 |
|
|
ROLE OF HLA/MHCII IN PARKINSON'S DISEASE PATHOGENESIS |
| 5R01NS092122-02 |
TANSEY, MARIA DE LOURDES G |
NINDS |
2016 |
|
|
UTE MAGNETIC RESONANCE IMAGING: NEW BIOMARKERS FOR MULTIPLE SCLEROSIS |
| 5R01NS092650-02 |
DU, JIANG |
NINDS |
2016 |
|
|
TEMPORAL PATTERNS OF DEEP BRAIN STIMULATION |
| 5R37NS040894-12 |
GRILL, WARREN M. |
NINDS |
2016 |
|
|
PHASE 3 TRIAL OF INOSINE FOR PARKINSON'S DISEASE CCC |
| 5U01NS090259-02 |
SCHWARZSCHILD, MICHAEL A |
NINDS |
2016 |
|
|
REGULATION OF NEUROGENESIS IN TSC BY MTORC1 AND MTORC2 |
| 6R01NS078289-05 |
ESS, KEVIN C |
NINDS |
2016 |
